Flowchart of the search process. by Razieh Bidhendi-Yarandi (7139387)

“…The results of meta-regression analyses revealed a statistically significant trend showing a gradual decrease in the prevalence of the composite outcome of anxiety and/or depression over time (RD = -0.004,P = 0.022). …”

We compared the Fugl-Meyer (FMA) clinical assessment scores for individuals with stroke with their performance for each outcome measure. by Devin Sean Austin (20285144)

CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

“…Occupation of the household head for rickshaw/van/cart puller, AOR, the odds increase even more, with the event being 3.15 times more likely for this occupation (95% CI: 1.95, 5.08) and statistical significance (p-value < 0.05). Again, for daily wager AOR, 2.16 times higher for daily wagers (95% CI: 1.35, 3.45) and statistical significance (p-value: 0.001). …”

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

“…Occupation of the household head for rickshaw/van/cart puller, AOR, the odds increase even more, with the event being 3.15 times more likely for this occupation (95% CI: 1.95, 5.08) and statistical significance (p-value < 0.05). Again, for daily wager AOR, 2.16 times higher for daily wagers (95% CI: 1.35, 3.45) and statistical significance (p-value: 0.001). …”

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The number, age, and weight of the patients with cleft lip and palate in the velar adhesion VA group and non-VA group. by Miki Kashiwagi (21439684)

Subjects:

Measurement of the patients’ dental cast models. by Miki Kashiwagi (21439684)

Subjects:

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

Velar adhesion (VA). by Miki Kashiwagi (21439684)

Subjects:

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. by Miki Kashiwagi (21439684)

Subjects:

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

Subjects:

Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

Subjects:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

Subjects:

Isotype control overlays. by Chen Lu (135200)

Subjects:

Original uncropped blot. by Chen Lu (135200)

Subjects:

Characterization of BM-MSC. by Chen Lu (135200)

Subjects:

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

Subjects: